Business Description
Firefly Neuroscience Inc
NAICS : 541519
SIC : 7376
ISIN : US3179701012
Total Employee Number:
13Description
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.77 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -12.55 | |||||
Beneish M-Score | 7.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -36.6 | |||||
3-Year EPS without NRI Growth Rate | -14 | |||||
3-Year FCF Growth Rate | -6.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.86 | |||||
9-Day RSI | 28.51 | |||||
14-Day RSI | 31.65 | |||||
3-1 Month Momentum % | -4.4 | |||||
6-1 Month Momentum % | 44.76 | |||||
12-1 Month Momentum % | -49.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.82 | |||||
Quick Ratio | 1.78 | |||||
Cash Ratio | 1.27 | |||||
Days Inventory | 50.84 | |||||
Days Sales Outstanding | 37.05 | |||||
Days Payable | 684.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.1 | |||||
Shareholder Yield % | -4.52 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.96 | |||||
Operating Margin % | -539.77 | |||||
Net Margin % | -565.4 | |||||
EBITDA Margin % | -550.19 | |||||
FCF Margin % | -493.06 | |||||
OCF Margin % | -481.76 | |||||
ROE % | -104.09 | |||||
ROA % | -73.3 | |||||
ROIC % | -139.3 | |||||
3-Year ROIIC % | -86.41 | |||||
ROC (Joel Greenblatt) % | -5261.51 | |||||
ROCE % | -103.33 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 10.2 | |||||
PB Ratio | 2.02 | |||||
Price-to-Tangible-Book | 7.19 | |||||
EV-to-EBIT | -1.89 | |||||
EV-to-EBITDA | -1.93 | |||||
EV-to-Revenue | 10.63 | |||||
EV-to-FCF | -2.16 | |||||
| Price-to-Net-Current-Asset-Value | 8.85 | |||||
| Price-to-Net-Cash | 28.75 | |||||
Earnings Yield (Greenblatt) % | -52.91 | |||||
FCF Yield % | -43.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AIFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Firefly Neuroscience Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.584 | ||
| EPS (TTM) ($) | -0.63 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 235.26 | ||
| 14-Day RSI | 31.65 | ||
| 14-Day ATR ($) | 0.103475 | ||
| 20-Day SMA ($) | 1.3025 | ||
| 12-1 Month Momentum % | -49.67 | ||
| 52-Week Range ($) | 0.6175 - 3.63 | ||
| Shares Outstanding (Mil) | 15.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Firefly Neuroscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Firefly Neuroscience Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 121 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 30 days | ||
| General meeting for 2026 | 2026-08-05 10:00 | In 23 days | ||
| First quarter earnings results for 2026 | 2026-05-13 | 1.80 (+1.12%) | ||
| Annual report for 2025 | 2026-03-31 | 2.20 (-0.45%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 1.65 (+1.23%) | ||
| General meeting for 2025 | 2025-10-27 10:00 | 2.08 (+0.97%) | ||
| Second quarter earnings results for 2025 | 2025-08-13 | 2.78 (+0.00%) |
Show
Entries
Firefly Neuroscience Inc Frequently Asked Questions
What is Firefly Neuroscience Inc(AIFF)'s stock price today?
The current price of AIFF is $1.15. The 52 week high of AIFF is $3.63 and 52 week low is $0.62.
When is next earnings date of Firefly Neuroscience Inc(AIFF)?
The next earnings date of Firefly Neuroscience Inc(AIFF) is 2026-08-13 Est..
Does Firefly Neuroscience Inc(AIFF) pay dividends? If so, how much?
Firefly Neuroscience Inc(AIFF) does not pay dividend.
Guru Commentaries on NAS:AIFF
No articles.
Press Release
Articles on Firefly Neuroscience Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers